
Credo Technology Group Holding Ltd
CRDONASDAQTechnology● Active
$222.27
+$15.38(+7.43%)
Market Cap$41.0B
P/E Ratio—
52W High$245.95
52W Low$66.75
Credo Technology Group Holding Ltd(CRDO)· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CRDO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-04 | 2024-04 | 2023-04 | 2022-04 | 2021-04 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.05B | ($0.03B) | ($0.02B) | ($0.02B) | ($0.03B) |
| Depreciation & Amort. | $0.02B | $0.01B | $0.01B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.08B | $0.04B | $0.02B | $0.01B | $0.00B |
| Change in Working Capital | ($0.11B) | ($0.00B) | ($0.05B) | ($0.03B) | ($0.02B) |
| Net Cash from Operations | $0.07B | $0.03B | ($0.02B) | ($0.03B) | ($0.04B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.04B) | ($0.02B) | ($0.02B) | ($0.02B) | ($0.01B) |
| Purchases of Investments | ($0.26B) | ($0.40B) | ($0.16B) | $0.00B | $0.00B |
| Sales of Investments | $0.41B | $0.17B | $0.05B | $0.00B | $0.00B |
| Net Cash from Investing | $0.11B | ($0.25B) | ($0.13B) | ($0.02B) | ($0.01B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | ($0.02B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | ($0.01B) | $0.18B | $0.00B | $0.20B | $0.08B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.03B | $0.02B | ($0.05B) | ($0.05B) | ($0.05B) |
| FCF Margin %(computed) | 2.17% | 3.91% | -24.01% | -26.28% | -45.47% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · B
深入了解Credo Technology Group Holding Ltd
关于Credo Technology Group Holding Ltd(CRDO)现金流量表
Credo Technology Group Holding Ltd 2025财年经营活动现金流$0.07B,自由现金流$0.03B(FCF利润率2.17%),资本支出($0.04B)。
常见问题
CRDO · 4 问Credo Technology Group Holding Ltd 2025财年自由现金流$0.03B,同比up69.9%。
CRDO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10